Statement Of Cash Flows [Abstract]

ERYTECH Pharma S.A. - Filing #2810992

Concept 2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations before changes in working capital
22 063 EUR
23 663 EUR
49 615 EUR
Increase (decrease) in working capital
2 071 EUR
8 097 EUR
7 153 EUR
Adjustments for decrease (increase) in trade and other receivables
218,000 EUR
63,000 EUR
8,000 EUR
Adjustments for increase (decrease) in trade and other payables
1 213 EUR
9 220 EUR
6 477 EUR
Adjustments for decrease (increase) in other current assets
923,000 EUR
2 734 EUR
94,000 EUR
Adjustments for increase (decrease) in other current liabilities
152,000 EUR
1 548 EUR
574,000 EUR
Adjustments for gains (losses) on change in fair value of derivatives
EUR
EUR
1 175 EUR
Cash flows from (used in) investing activities [abstract]
Purchase of financial instruments, classified as investing activities
4,000 EUR
5,000 EUR
192,000 EUR
Proceeds from sales or maturity of financial instruments, classified as investing activities
360,000 EUR
586,000 EUR
145,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.